Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 475 (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $ACRG_A_U.C) (TSX: $TGOD.TO) (CSE: $HAVN.C)
Today’s
podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed
cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, October 1, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/100120-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/10011WEED-CGC-ACRG-TGOD-HAVN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully
licensed cannabis cultivation and distribution company in Switzerland, for
recreational tobacco products and medical CBD oils. The Company's facilities
for producing cannabis are based in Dietikon, Switzerland, and contain the art
surveillance equipment to enable an around the clock webcast. Cannabis Suisse
grows high quality, organic cannabis with sustainable, all-natural principles.
The Company's products are laboratory tested to ensure the end users have
access to a standardized, safe and consistent product. Cannabis Suisse
proprietary trademarked MoldStandard is a quantitative microbiology method for
analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse
proprietary trademarked CannaMec is a method for quantifying and removing
residual solvents during packaging and storage of CBD products. Cannabis Suisse
Corp. currently sells via a distribution network of Swiss retailers and online
shops, under the retail brand Alpine Cannabis.
In
today’s podcast we look at a few public and private company announcements.
Canopy
Growth Corporation (TSX:WEED) (NYSE:CGC) and Acreage Holdings, Inc. (CSE:ACRG.A.U) (OTC:
ACRHF) announced
today that following the implementation of their amended
arrangement, Acreage has developed a plan to market Canopy Growth's diverse
beverage portfolio in the United States.
Leading with legal adult-use markets
in Illinois and California, Acreage anticipates launching Canopy Growth's
select, sessionable THC beverage formulations in summer 2021. In addition to
selling products in its own dispensaries, Acreage will access existing
distribution channels through strategic corporate relationships.
"We have had an incredibly
successful introduction into the Canadian cannabis-infused beverage industry
with over 1.7 million cans of our THC-infused RTD beverages, like Tweed's Houndstooth & Soda and Bakerstreet & Ginger sold to
date," shared Canopy Growth CEO, David Klein. "We introduced a new
product category to cannabis consumers that we knew had the potential to
disrupt one of the most mature industries and since launching in Canada, Canopy
Growth now owns 5 of the top 6 SKUs in the beverage category with a 74% market
share. We are excited for Canopy's beverages to be introduced to the U.S.
market next summer."
"We see THC-infused beverages
as a game-changer in U.S. cannabis, and we are excited to launch Canopy
Growth's unique beverage offerings to our core markets offering the greatest
growth potential next year," said Bill Van Faasen, Interim CEO of Acreage
Holdings. "We are already working on our beverage production capabilities,
and look forward to tapping the wealth of experience and research Canopy can
offer following its successful entry in the category last year."
The Companies look forward to
bringing a sessionable infused beverage offering to U.S. consumers that will
more closely liken itself to current beverage-alcohol serving sizes.
The
Green Organic Dutchman Holdings Ltd. (TSX:
TGOD) (OTC:
TGODF), a leading producer of premium certified organically
grown cannabis, announced that it
has received import licences from the Australian and German authorities, and
has applied for export licences with Health Canada.
These licences enable TGOD to export
its premium certified organically grown products for validation. The Company anticipates validation will be
completed by the end of the year and is on track to commence commercial export
of medical cannabis products in 2021.
"TGOD was the first certified
organic Canadian licensed producer to be granted an EU-GMP certificate. Today we are one step closer to fulfilling
our vision of becoming the leading organic cannabis brand globally,"
commented Brian Athaide, CEO of TGOD. "Obtaining import licences from
Australia and Germany is testament to the robust quality assurance system we
have implemented across our operations and supply chain. We look forward to providing access to our
high-quality products to Australian and German patients," added Athaide.
TGOD signed a distribution agreement
with Australia's LeafCann and has access to a vast network in Europe through
its wholly owned subsidiary, TGOD Europe.
The Company expects to complete its first commercial shipment in 2021.
LYTE
Clinics
announced
joining
the University Health Network and Medical Cannabis by Shoppers in a
first-of-its-kind Real World Evidence study with medical cannabis.
The Medical Cannabis Real-World
Evidence (MC-RWE) clinical trial will allow patients to select medical cannabis
products that are tested, from seed straight through to packaging. Patients
using the online portal created by Medical Cannabis by Shoppers, will know
exactly what is in their product: how many milligrams of THC and cannabidiol
are being consumed, and if it works for them, they can rely on the product
being exactly the same, from batch to batch. Patients in the MC-RWE clinical
trial will have access to a wide range of products including dried flower, oil
extracts, edibles, and topical preparations through the portal, which is the
online platform for the sale of medical cannabis by Canadian retail pharmacy
chain, Shoppers Drug Mart.
LYTE Clinics' practitioners will
assist patients in enrolling in the study, as well as offering support and
medical advice to participants so that they can select the best products for
their medical cannabis therapy.
LYTE is unique amongst cannabis
clinics as the process of scheduling an appointment with a doctor, registering
with a medical provider, and placing an order is all done online in a matter of
minutes, using state-of-art telehealth software, with the benefit of minimizing
wait time.
"LYTE's robust telemedicine
platform will connect Canada's largest pharmacy network, Shoppers Drug Mart,
with Canada's largest and most prestigious research institution, University
Health Network, to enable this groundbreaking clinical study in medical
cannabis." States Dr Dean Elterman, of University Health Network.
"Patients and practitioners
need rigorously tested, genetically verified, fully tracked medical cannabis
options, noted Ali Mohamed, President & CEO of Lyte Clinics. "The
information gathered in the Medical Cannabis Real-World Evidence Study is
critical to helping new patients find the type of cannabis that is proven to be
best for their symptoms, which will lead to a better quality of life for
thousands of Canadians."
Havn
Life Sciences Inc. (CSE:HAVN), a
biotechnology company focused on unlocking human potential using
evidence-informed research, and developing standardized psychoactive compounds
derived from plants and fungi, announced that it
has joined the Drug Science Medical Psychedelics Working Group consortium.
The working group was launched by
Drug Science, the UK's leading independent scientific body on drugs that
provides an evidence base that is free from political or commercial influence,
which creates a foundation for sensible and effective drug laws by delivering,
reviewing, and investigating scientific evidence relating to psychoactive
drugs.
"Havn Life is thrilled to be
supporting Drug Science's research on psychedelics," said Dr. Ivan
Casselman (Ph.D., FLS), Havn Life's Chief Psychedelic Officer. "We are
committed to advancing research in psychedelics, as well as collaborating with
organizations and academic institutions around the world to tap into
world-class, quality research. The development of sensible drug policy reform
is a mission that both the working groups and Havn Life are highly aligned
with."
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Investors can trade these stocks
and other ideas on our site using our list of top stock trading
apps including Robinhood, Acorn,
Stash and others.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: Cannabis
Suisse Corp. (OTC: CSUI ),is
a paid featured company on Investorideas.com More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
